C9orf72 and autoimmune polyendocrinopathy: We screened 77 patients with pathologically confirmed CBD and 549 patients with clinically diagnosed PSP (n = 366), CBS (n = 130), and APS (n = 53) for intermediate repeat expansions in C9orf72. The demographic characteristics of participants are shown in Table 1.